What's New
[8/24]MedRIC-APAN NanoMedicine & Cancer ±¹Á¦¼¼¹Ì³ª ¾È³»
°ü¸®ÀÚ | 2011-08-22 ¿ÀÈÄ 1:30:33 |  Á¶È¸ 1370

¾È³çÇϽʴϱî?

±¹°¡ÁöÁ¤ ÀÇÇבּ¸Á¤º¸¼¾ÅÍ¿Í ¾Æ½Ã¾ÆÅÂÆò¾çÃÊ°í¼Ó¿¬±¸¸Á, ±¹¸³¾Ï¼¾ÅÍ¿¡¼­´Â Á¤º¸È­½Ã´ë ÀÇÇבּ¸¼¼¹Ì³ªÀÇ ±¹Á¦±³·ù È°¼ºÈ­¸¦ À§Çؼ­ ±¹Á¦¼¼¹Ì³ª¸¦  ±¹³» ÃÖÃÊ·Î ½º¸¶Æ®ÆùÀ¸·Î ½Ç½Ã°£ Á߰踦 ÇϰԵǾú½À´Ï´Ù.

½Ã°£Ç¥¸¦ º¸½Ã°í ÇØ´ç ½Ã°£¿¡ ½º¸¶Æ®ÆùÀ¸·Î ¸¹Àº ½Ãû¹Ù¶ø´Ï´Ù

 

2011. 8. 22. ±¹°¡ÁöÁ¤ ÀÇÇבּ¸Á¤º¸¼¾ÅÍ ¿Ã¸².


³ª³ë ±â¼úÀº ¾ÏÀÇ Áø´Ü ¹× Ä¡·á ºÐ¾ß¿¡ À־ ±âÁ¸ÀÇ ¹æ½ÄÀ» ȹ±âÀûÀ¸·Î ¹Ù²Ü ¼ö ÀÖ´Â °­·ÂÇÑ °¡´É¼ºÀ» º¸¿© ÁÖ°í ÀÖ´Ù. ÃÖ½ÅÀÇ ±×¸®°í ´Ù±â´ÉÀ» °®Ãá ³ª³ë ÀǾàÇ° µéÀº ¾ÏÀ» Ãʱ⠴ܰ迡¼­ Áø´ÜÇÒ ¼ö ÀÖµµ·Ï ÇØÁÖ°í, ¸ö ¼Ó¿¡ Á¸ÀçÇÏ´Â ¾ÏÀÇ À§Ä¡¸¦ ²À Âó¾î¼­ Á¤È®È÷ º¸¿©ÁÙ ¼ö ÀÖÀ» »Ó ¾Æ´Ï¶ó ¾î¶°ÇÑ Ç×¾ÏÁ¦¿¡ Àß ¹ÝÀÀÇÒ °ÍÀÎÁö¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÑ´Ù. ¶ÇÇÑ, Ç×¾ÏÁ¦¸¦ ¾Ï Á¶Á÷¿¡¸¸ ƯÀÌÀûÀ¸·Î Àü´ÞÇÔÀ¸·Î½á ±âÁ¸ÀÇ Ç×¾ÏÁ¦°¡ Á¤»ó Á¶Á÷¿¡µµ ÃàÀûµÇ´Â °Í¿¡ ÀÇÇؼ­ ³ªÅ¸³µ´ø ½É°¢ÇÑ ¾à¹° ºÎÀÛ¿ëÀ» ȹ±âÀûÀ¸·Î ÁÙÀÏ ¼ö ÀÖ°í, Ç×¾ÏÁ¦ ³»¼ºÀ» º¸ÀÌ´Â ¾ÏÀÇ Ä¡·á¿¡µµ È¿°ú°¡ ÀÖ´Ù´Â °ÍÀ» º¸¿© ¿Ô´Ù. ÃÖ±Ù¿¡ °³¹ßµÇ°í ÀÖ´Â »ýü ¹ÙÀÌ¿À ¼¾¼­µéÀº ±âÁ¸ÀÇ ±â¼ú·Î´Â °ËÃâÇØ ³»Áö ¸øÇß´ø ¾ÆÁÖ ÀÛÀº Á¾¾ç µé ¹× ÀüÀÌ ¾Ï ¼¼Æ÷µéÀÇ Á¸Àç ¹× À§Ä¡¸¦ Áø´ÜÇØ ³¾ ¼ö ÀÖÀ» »Ó ¾Æ´Ï¶ó, ȯÀÚ¿¡°Ô Åõ¿©µÈ Ä¡·áÁ¦Á¦°¡ Ç¥ÀûÀ¸·Î ÇÏ´Â ¾Ï¼¼Æ÷ ³» ºÐÀÚ¿¡ ½ÇÁ¦·Î ÀÛ¿ëÀ» ÇÏ°í ÀÖ´ÂÁö¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ ¿µ»óÀ¸·Î Á¦°øÇØ ÁÜÀ¸·Î½á ¾Ï ÀÇ Áø´Ü ¹× Ä¡·á¿¡ Ä¿´Ù¶õ º¯È­¸¦ ÀÏÀ¸Å³ °ÍÀ¸·Î ¿¹»óµÈ´Ù.

¾ÏÀÇ Áø´Ü ¹× Ä¡·á¿¡ À־ÀÇ ÀÌ·¯ÇÑ ³ª³ë ÀǾàÇ°ÀÇ ¹«ÇÑÇÑ °¡´É¼º¿¡ µû¶ó¼­, NCI´Â Alliance for Nanotechnology in Cancer ÇÁ·Î±×·¥À» 2004³âºÎÅÍ °³½ÃÇÏ¿´À¸¸ç, ¾ÏÀÇ Áø´Ü,Ä¡·á, ¿¹¹æÀ» À§ÇÏ¿© 5³â¿¡ °ÉÃļ­ ¾à 1¾ï 5õ¸¸ºÒ¿¡ À̸£´Â ¸·´ëÇÑ ¿¬±¸ºñ¸¦ Áö¿øÇØ ¿À°í ÀÖ´Ù. ÇöÀç ¹Ì±¹¿¡´Â MIT-Harvard Center of Cancer Nanotechnology Excellence¸¦ Æ÷ÇÔÇÏ¿© 9°³ÀÇ ¶Ù¾î³­ ¾Ï ³ª³ë±â¼ú ¼¾ÅÍ°¡ Á¸ÀçÇϸç, ÀÌ·¯ÇÑ ³ª³ë¼¾Å͵éÀº »õ·Î¿î ³ª³ë±â¼ú °³¹ß°ú À̵éÀÇ ½ÇÁ¦ ÀÓ»ó Àû¿ë¿¡ °üÇÑ ¿¬±¸¿¡ ÁßÃßÀûÀÎ ¿ªÇÒÀ» ¼öÇàÇÏ°í ÀÖ´Ù.

 º» ºñµð¿À ½ÉÆ÷Áö¿ò¿¡¼­´Â NCI Alliance for nanotechnology in Cancer µð·ºÅÍÀÎ Piotro Grodzinski ¹Ú»çÀÇ ³ª³ë ±â¼ú°ú ±âȸ ¹ßÇ¥¿Í, UCLA È­ÇаúÀÇ ¼®Á±³¼öÀÎ Jeffrey I Zink ¹Ú»çÀÇ ´Ù±â´É¼º ½Ç¸®Ä« ³ª³ëÀÔÀÚ¸¦ ÀÌ¿ëÇÑ ¾Ï Áø´Ü ¹× Ä¡·á ¿¬±¸¸¦ Æ÷ÇÔÇÏ¿©, ¾ÏÀÇ Áø´Ü, Ä¡·á, ¿¹¹æ¿¡ À־ ³ª³ë ±â¼úÀÇ ¹«ÇÑÇÑ °¡´É¼º°ú ÀÌ·¯ÇÑ ³ª³ë ±â¼úµéÀ» ¾ÏȯÀÚ¿¡°Ô Àû¿ëÇϱâ À§Çؼ­ ¿ì¸®°¡ ±Øº¹ÇØ¾ß µÉ ¹®Á¦Á¡µé¿¡ ´ëÇؼ­, ³ª³ë±â¼úÀ» ¼±µµÇÏ°í ÀÖ´Â ¹Ì±¹±¹¸³¾Ï¼¾ÅÍ, ¹Ì±¹ Ä̸®Æ÷´Ï¾Æ ³ª³ë½Ã½ºÅÛ ¿¬±¸¼Ò, Áß±¹ ³ª³ë°úÇÐ ±â¼ú ±¹¸³ ¿¬±¸¼¾ÅÍ, Çѱ¹ ±¹¸³¾Ï¼¾ÅÍÀÇ ¿¬±¸ÀÚµéÀÌ ¸ð¿©¼­ Åä·ÐÇÏ°Ô µÈ´Ù.


Program of Healthcare session-1: International Collaborative Research on Cancer and Nanotechnology

 

Date: 7:00-10:30, August 24 IST

India

7:00–10:30, August 24

China

9:30-13:00, August 24

Korea

10:30-14:00, August 24

LA, USA

18:30-22:00, August 23

Bethesda, USA

21:30, August 23 – 01:00, August 24

 

Organizers: YoungSung Lee, Ed Johansen

Chairperson:  YoungSung Lee

USA moderator: Fuyu Tamanoi
Korea moderator: Yongdoo Choi

 

System: Polycom and its compatibles

Engineers in charge: Juyong Lee, Byoung-Ki Koo

Local engineer:Ti-Chuang Chiang

 

Connecting stations

1. APAN Meeting Room (New Delhi)

Network engineer: Ti-Chuang Chiang

 2. NCC (Ilsan, Korea)

    Network engineer: Juyong Lee, Byoung-Ki Koo

 3. NCI (Bethesda, USA)

    Network engineer: Todd Cox

4. NCI (Fredericks, USA)

Network engineer: Todd Cox

5. UCLA(LA, USA)

    Network engineer: Noushig Karpanian

 6. NCNST (Beijing, China)

Network engineer: Dongliang Wang

 

Session 1-a
Time:
7:00-7:30 IST

 

Speakers
1.Jin-Soo Lee (NCC, Korea)
2.Judith C. Gasson (UCLA, USA)
3.Piotr Grodzinski (NCI, USA): ¡°
Cancer Nanotechnology – Opportunities and Challenges – View from the NCI Alliance for Nanotechnology in Cancer¡±


Session 1-b
Time: 7
:30-9:00 IST

 

Speakers
1.Anil K. Patri (NCI, USA): ¡°Resources for Preclinical Assessment of Nanomaterials¡±
2.Jacob Berlin (City of Hope, Duarte, USA): ¡°Carbon-based Nanovectors for targeted paclitaxel delivery¡±

3. Jose Galvez (NCI, USA): ¡°International Cancer Research Programs¡±

4. Jeffrey I. Zink (UCLA, USA): ¡°Multifunctional Mesoporous Nanoparticles for Targeting, Imaging and Drug Delivery¡±

5. Hsian-Rong Tseng(UCLA, USA): "Nano-velcro for Identification and Isolation of Circulating Tumor cells from Whole Blood"

6. Fuyu Tamanoi (UCLA, USA): ¡°Anti-tumor Efficacy of Camptothecin-loaded Mesoporous Nanoparticles¡±

 

Break: 9:00-9:10 IST

 

Session 1-c
Time:
9:10-10:30 IST

 

Speakers
1. Xingyu Jiang (NCNST, Beijing, China): ¡°What nanoparticles could do to improve the quality of in vitro diagnostic assays?¡±

2. Xing-Jie Liang (NCNST, Beijing, China): ¡°Unique Biological and Medical Effects of Structures with Nanoscale Characterizations¡±
3. Amit Dinda (All Institute of Medical Sciences, New Delhi, India): ¡°Cancer cell targeting with nanoparticle for drug delivery; The therapeutic and safety issues¡±
4. Sangyong Jon (Gwangju Institute of Science and Technology, Korea): ¡°Aptide-based Nanomedicine for Cancer Imaging and Therapy¡±

5. Ji Ho Park (Korea Advanced Institute of Science and Technology, Korea): ¡°A Systems Approach to Engineering Cancer Nanotechnologies¡±